We demonstrated that the anticancer activity of PPD in colon cancer cells is at least in part due to the downregulation of multiple signaling pathways, noticeably MAPK/ERK, MAPK/JNK and NF-κB. Here, NFKB1 is linked to malignant colon neoplasm.